ImageneBio is a San Diego biopharmaceutical company developing IMG-007, an experimental antibody for autoimmune and inflammatory diseases. It last closed at $3.92 on Nov 20, down 1.51% on the day. The next earnings report for IMA is expected around Tue, Mar 9, 2027. For the quarter ended Sep 2026, IMA reported EPS of -$0.91. Over its last 5 reports the stock moved an average of 3.7% the session after earnings. Over the last 12 months IMA insiders bought $96K of stock on the open market and sold $17K, according to SEC Form 4 filings.
AI Auto Pilots
Is IMA in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IMA.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on IMAStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
IMA · as of the Nov 20 close · updated each morning
Downtrend
The stock sits between its 20 and 50 day averages. It is 38% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 48). The nearest support is the 20 day average at $3.91, and the nearest resistance the Pivot R1 at $4.05.
Short trendBearish
Long trendBearish
MomentumImproving
StretchNormal
VolatilityHigh, 7.7%/day
Key levels
$7.6952 week high+96.2%
$5.39200 day average+37.5%
$4.93100 day average+25.8%
$4.2750 day average+8.9%
$4.10Swing high (Nov 17)+4.6%
$4.05Pivot R1+3.3%
$3.92Pivot+0.0%
$3.92Last close
$3.9120 day average−0.3%
$3.90Swing low (Oct 9)−0.5%
$3.79Pivot S1−3.3%
$3.0052 week low−23.5%
Indicators
RSI (14)
48.30
Middle of its range
Neutral
MACD
-0.15
Above its signal line
Bullish
Stochastic
69.5
Middle of its range
Neutral
ADX (14)
20.1
Weak trend
Williams %R
-29.2
Oversold below −80, overbought above −20
Neutral
CCI (20)
-0.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.5%
Change over 10 sessions
Bearish
ATR (14)
$0.30
Typical daily range, 7.7% of price
MA 10Above
MA 20Above
MA 50Below
MA 100Below
MA 200Below
Falling, nearing oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityNormal, 16.9%/day
Key levels
$7.6952 week high+96.2%
$5.39200 day average+37.5%
$4.93100 day average+25.8%
$4.2750 day average+8.9%
$4.10Swing high (Nov 17)+4.6%
$4.05Pivot R1+3.3%
$3.92Pivot+0.0%
$3.92Last close
$3.9120 day average−0.3%
$3.90Swing low (Oct 9)−0.5%
$3.79Pivot S1−3.3%
$3.0052 week low−23.5%
Indicators
RSI (14)
33.99
Weak, oversold below 30
Neutral
MACD
-0.60
Below its signal line
Bearish
Stochastic
14.3
Near the bottom of its range
Oversold
ADX (14)
44.3
Strong downtrend
Williams %R
-71.3
Oversold below −80, overbought above −20
Neutral
CCI (20)
-126.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−22.8%
Change over 10 sessions
Bearish
ATR (14)
$0.66
Typical daily range, 16.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100–
MA 200–
What happened before, for IMA
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IMA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow IMA usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for IMAHow many large options trades hit IMA, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in IMA in the last 90 days.
From SEC Form 4 filings by IMA's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IMA is in one of them and how their past IMA trades turned out.
ImageneBio is a biopharmaceutical company based in San Diego, California, that is developing treatments for immunological, autoimmune and inflammatory diseases. Its main candidate, IMG-007, is an experimental antibody that targets the OX40 receptor on activated T cells. The company is still in clinical trials and is first testing the candidate in atopic dermatitis, a common form of eczema, with plans to study other conditions. Its intended patients are people with these diseases, and its treatments would be prescribed by physicians.